This framework discusses drug design methods and factors impacting cellular performance of protein degraders, implying new design strategies.
assays and provide a concise framework for prioritizing and mapping them to decision stages. We also discuss the main factors affecting degrader's cellular performance and principles that have emerged to guide drug design.
No takes yet. Share an insight, caveat, or question.
Crowe et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: